Achillea Millefolium

Introduction Overview

Generic Name

Achillea millefolium

Brand Name

Yarrow

Dosage Form

Herbal preparations including aerial herb parts used as teas, extracts, ointments, creams, dried herb, and powdered forms

Drug Class

Herbal remedy, traditional phytotherapeutic agent, Asteraceae family

Pharmacokinetics

Pharmacokinetic data of Achillea millefolium (Yarrow) are not extensively characterized in human clinical literature, as this is primarily a traditional herbal medicine with limited formal pharmacokinetic studies. However, traditional use and chemical composition provide insights into absorption, distribution, metabolism, and elimination:

Absorption: Yarrow preparations such as teas and ethanol or hydroalcoholic extracts are orally administered; the flavonoids, sesquiterpene lactones, essential oils including azulenes and chamazulene are likely absorbed via the gastrointestinal tract upon consumption. The moderate lipophilicity of volatile oils suggests rapid absorption but variable bioavailability, dependent on extraction method and formulation. Lack of clinical pharmacokinetic studies limits definitive absorption parameters.

Distribution: Once absorbed, compounds such as flavonoids and sesquiterpene lactones likely bind plasma proteins and distribute to various tissues. The extracts exhibit pharmacologic effects on vascular smooth muscle and renal tissues in animal models, suggesting tissue penetration. However, specific volume of distribution or tissue concentration data is lacking.

Metabolism: Metabolism is presumed to occur hepatically, with phase I and II reactions modifying flavonoids, sesquiterpenes, and volatile oils to more polar metabolites facilitating elimination. Components like thujone are known to undergo hepatic metabolism. The metabolic pathways follow typical herbal constituents' biotransformation circuits, but concrete human metabolic pathways remain to be elucidated.

Elimination: Metabolites are presumed to be excreted renally and biliarily as conjugated species. Animal studies suggest renal involvement, but human elimination half-life and clearance are undetermined. The presence of diuretic effects in animal models indicates possible renal interactions affecting elimination. Overall, detailed pharmacokinetic profiling is scant due to the botanical nature of the drug and lack of standardization in clinical research.

Dosage Forms

Available Dosage Forms:
- Dried aerial herb parts used as infusions or teas.
- Ethanol or hydroalcoholic extracts of aerial parts (flowers, leaves, and stems).
- Topical ointments and creams prepared from Achillea millefolium extract for wound healing and mucosal application.
- Vaginal creams containing standardized extracts for vulvovaginal candidiasis.

Dosages for Adults and Adolescents:
- Traditional oral usage typically involves approximately 4.5 grams per day of Yarrow herb in dried form.
- Clinical studies have utilized extracts equivalent to 2 to 4 grams of dry flowers (e.g., 250 mg and 500 mg of flower extract) daily in multiple sclerosis relapses.
- Vaginal cream applications for candidiasis involve twice-daily topical usage over treatment courses evaluated in clinical trials.
- For dysmenorrhea, Yarrow tea consumed three times daily for three days has been studied for pain relief.
- No standardized dosing regimens are universally accepted; clinical data are limited.

Specific Patient Populations:
- Use is contraindicated in pregnancy and lactation due to potential abortifacient effects of thujone and insufficient safety data.
- Caution advised in patients with known hypersensitivity to plants in the Asteraceae family due to risk of contact dermatitis.
- Insufficient data available for pediatric dosing; use not recommended in children under 2 years.
- Limited clinical data in patients with epilepsy; no contraindications but careful monitoring recommended.
- No dose adjustments established for renal or hepatic impairment given lack of pharmacokinetic studies.

Note: Commercial preparations must be thujone-free to minimize abortifacient risk.

Mechanism Of Action

Achillea millefolium exerts its multifaceted pharmacological effects through a complex interplay of its diverse phytochemical constituents, primarily flavonoids, sesquiterpene lactones, essential oils, and tannins.

At the molecular level, its primary anti-inflammatory action arises from inhibition of key pro-inflammatory mediators. Flavonoids such as apigenin, luteolin, and casticin exert inhibitory effects on cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, thereby alleviating inflammation and associated symptoms. Additionally, suppression of nuclear factor kappa B (NF-κB) pathway activation lowers cytokine release, notably interleukin-1 beta (IL-1β) and inducible nitric oxide synthase (iNOS), as demonstrated in animal models, which correlates with reduction in oxidative stress and inflammation.

The essential oil fraction, which contains azulene and chamazulene, contributes antioxidative and antispasmodic properties. These compounds stabilize free radicals and inhibit reactive oxygen species (ROS) production, protecting tissues from oxidative damage. The antispasmodic effect involves modulation of smooth muscle contractility through interaction with muscarinic and adrenergic receptors, evidenced by guinea pig tracheal tissue studies showing relaxation via muscarinic receptor inhibition and beta-adrenoceptor agonism.

Yarrow’s antimicrobial mechanism is mediated through mild inhibition of pro-inflammatory signaling in infected gastric epithelial cells, suppressing IL-8 secretion and ROS generation, thereby exerting cytoprotective effects despite limited direct bactericidal activity. Some sesquiterpene lactones within yarrow exhibit selective cytotoxicity towards protozoal pathogens and human cancer cell lines by inducing apoptosis and disrupting mitochondrial function.

Clinically, these mechanisms translate into observed benefits such as reduced relapse rates in multiple sclerosis, wound healing acceleration via anti-inflammatory and antimicrobial actions, and symptomatic relief in dysmenorrhea and vulvovaginal candidiasis. While sharing anti-inflammatory pathways with similar Asteraceae botanical drugs like chamomile and feverfew, yarrow’s unique combination of flavonoids and essential oils gives it distinct therapeutic profiles validated mostly through preclinical and limited clinical evidence.

Pharmacological Actions

Anti-inflammatory effects through inhibition of prostaglandin synthesis and cytokine modulation.
Antioxidant activity via free radical scavenging and reduction of reactive oxygen species.
Antimicrobial and antiprotozoal activity against certain bacterial and protozoal pathogens.
Antispasmodic effects on smooth muscle mediated by muscarinic receptor interaction.
Diuretic properties via activation of bradykinin B2 receptors and cyclooxygenase pathways.
Hypotensive effects demonstrated in animal models through vascular smooth muscle relaxation.
Immunomodulatory actions, including modulation of dendritic cell maturation.
Cytotoxic and antitumor activity against various human cancer cell lines by inducing apoptosis.
Wound healing acceleration attributed to anti-inflammatory and antimicrobial constituents.
Anxiolytic-like effects demonstrated in preclinical models.
Anticholinergic effects observed at high doses, caution warranted.
Insect repellent properties derived from essential oil components.
Protection against nephrolithiasis and oxidative renal damage in animal studies.

Therapeutic Or Clinical Uses

Traditional use for inflammatory disorders, appetite loss, and dyspepsia.
Adjunct therapy in multiple sclerosis to reduce relapse rates and prolong time to relapse.
Topical treatment of wounds and episiotomy sites to reduce pain and inflammation.
Management of primary dysmenorrhea with reduction in pain severity.
Supportive treatment of vulvovaginal candidiasis with local application of creams.
Potential use as a mild diuretic in clinical and traditional settings.
Adjunct in irritable bowel syndrome symptom management (limited clinical data).
Use in chronic kidney disease to potentially modulate plasma nitrite/nitrate levels (preliminary data).
Traditional hemostatic agent, although lacking robust clinical validation.
Prophylactic applications in oral mucositis for cancer patients as an adjunct mouthwash.
Astringent and tonic used historically for general health promotion.
Cosmetic ingredient for skin rejuvenation and cleansing effects.
Potential insect repellent in traditional formulations.
Experimental uses in neurodegenerative disorders based on flavonoid content.
May support antimicrobial defense particularly against protozoal infections.

Side Or Adverse Effects

Contact dermatitis, especially in individuals allergic to plants of the Asteraceae family.
Potential anticholinergic adverse effects at high oral intake (e.g., multiple cups of tea).
Hypersensitivity reactions including skin rashes reported in rare instances.
Possible abortifacient effects due to thujone content, contraindicated in pregnancy.
Mild gastrointestinal discomfort reported with oral use in some cases.
No well-documented systemic toxicity at traditional doses.
Weak genotoxic potential suggested by limited studies, clinical relevance uncertain.
Antispermatogenic effects observed in animal models; human relevance unknown.
Possible interaction risks with diuretic medications requiring monitoring.
No significant adverse effects reported in clinical trials with standardized extracts.
Hypotensive pressure effects could be relevant in patients on antihypertensive therapy.
Risk of allergic reaction increased in sensitive individuals with Asteraceae allergy.
No reports of serious hepatotoxicity or nephrotoxicity at customary doses.
Photosensitivity reactions not commonly reported but theoretically possible.
Insufficient data to conclude safety in lactation and young children.

Precautions

Avoid use in patients with known allergy to Asteraceae (daisy) family plants due to risk of hypersensitivity.
Not recommended during pregnancy or breastfeeding due to abortifacient potential and insufficient safety data.
Use cautiously when combined with diuretics because of potential additive effects.
Monitor for signs of anticholinergic toxicity with high doses or prolonged use.
Patients with epilepsy should consult physicians prior to use as safety data are lacking.
Not established as safe for use in pediatric populations under 2 years of age.
Avoid self-medication in absence of established clinical guidelines due to limited human data.
Use standardized extracts free of thujone to minimize toxic risks.
Topical preparations should be patch tested prior to widespread use to check for contact dermatitis.
Caution in patients with hypotension or on antihypertensive medications.
Use with care in individuals with renal impairment given diuretic activity and lack of formal studies.
Avoid ingestion of large quantities as excessive use may precipitate adverse central nervous system effects.
Consider potential interactions with other herbal supplements that affect smooth muscle or diuresis.
Inform healthcare providers of yarrow use prior to surgery or medical procedures due to potential bleeding risk or interactions.
Patients should discontinue use if signs of allergy or adverse reactions develop.

Warnings

Contraindicated in individuals allergic to members of the Asteraceae family to prevent allergic reactions.
Avoid during pregnancy and lactation because of potential abortifacient effects linked to thujone.
Use with caution in patients on diuretics or antihypertensives due to risk of hypotension or electrolyte imbalance.
High doses or chronic use may lead to anticholinergic adverse effects, including dry mouth, blurred vision, or tachycardia.
Contact dermatitis is the most commonly reported adverse effect; discontinue if skin reactions occur.
Safety and efficacy in epilepsy and pediatric patients have not been established; use is not recommended.
Potential genotoxicity observed in limited studies necessitates caution in long-term use.
Commercial products must be thujone-free to avoid toxicity; adulterated products pose risks.
Self-treatment for serious conditions not advised; consult healthcare provider prior to use.
Interference with laboratory tests or surgical outcomes cannot be ruled out; inform medical teams about herbal use.
May potentiate effects of other agents with hypotensive or diuretic activity, requiring monitoring.
Not approved by FDA for treatment of any specific medical condition; quality and concentration may vary.
Overuse or misuse can lead to unidentified toxicities given the complexity of herbal constituents.
Consumers should be aware of the patchy scientific evidence base supporting therapeutic claims.
Discontinue use and seek medical advice if systemic symptoms like dizziness, palpitations, or severe rash develop.

Contraindication

Known hypersensitivity or allergy to Achillea millefolium or any other plant in the Asteraceae (daisy) family.
Pregnancy due to abortifacient risk from thujone content.
Lactation owing to insufficient safety data and potential adverse effects on the infant.
Children under 2 years due to lack of safety and efficacy data.
Patients with history of severe allergic dermatitis related to herbal products.
Use of non-standardized or adulterated yarrow preparations containing potentially toxic compounds.
Concomitant use with medications where diuretic or hypotensive effects pose clinical risks without supervision.
Epilepsy caution: although no definitive contraindication exists, safety data are lacking, thus use is generally discouraged.
Known or suspected genotoxic risk conditions or hypersensitivity to flavonoids and sesquiterpene lactones.
Avoid use if planning surgery or invasive medical procedures without informing the medical personnel.
Individuals with severe renal or hepatic impairment until more data become available.
Use contraindicated in cases with active skin sensitivity to topical herbal products containing yarrow.
Contraindicated if previous anticholinergic adverse reactions to yarrow or related herbs have occurred.
Use not recommended with other abortifacient agents due to cumulative risk.

Drug Interactions

Potential additive diuretic effect when used concomitantly with pharmaceutical diuretics leading to electrolyte imbalances.
Possible pharmacodynamic interaction with antihypertensive agents resulting in enhanced hypotensive effects.
Theoretical risk of interference with anticoagulant or antiplatelet agents is low but cannot be entirely excluded due to lack of data.
No well-documented direct interactions with cytochrome P450 metabolized drugs; however, caution advised given herbal nature.
Synergistic central nervous system effects possible when combined with other anticholinergic medications.
Concurrent use with other herbal supplements containing flavonoids or sesquiterpene lactones may lead to unpredictable effects.
No known interaction with commonly used antibiotics or antivirals, although clinical data are limited.
Topical application is unlikely to cause systemic interactions but local sensitization reactions may alter drug absorption.
No significant interaction reported with immunomodulatory agents but monitoring advised.
Use with other hypoglycemic agents has not been studied; caution is prudent.
Potential interference with laboratory tests or diagnostics depending on extract constituents.
No documented interaction with contraceptives; however, abortifacient potential mandates caution.
Interactions with CNS depressants have not been observed but should be monitored given anxiolytic activity.
No interactions reported with vaccines or common supplements such as vitamins and minerals.
Herb-drug interactions remain poorly studied; patients should inform healthcare providers of yarrow use.

Preparations Of The Drug

Dried Achillea millefolium aerial parts (leaves, flowers, and stems) for infusion or decoction.
Standardized ethanol or hydroalcoholic extracts containing quantified flavonoid and sesquiterpene lactone content.
Essential oil preparations containing azulene, chamazulene, borneol, pinenes, and cineole obtained by steam distillation.
Topical ointments and creams formulated from plant extracts for wound healing and mucosal applications.
Vaginal creams containing Achillea millefolium extract standardized for clinical use in vulvovaginal candidiasis.
Powdered herb capsules for oral use in traditional dosing regimens.
Cosmetic products including cleansers and skin rejuvenation formulations incorporating yarrow extracts free of thujone.
Teas made from dried herb traditionally prepared and consumed for various indications.
Combination herbal formulations including yarrow alongside other botanicals for synergistic effects.
Herbal tinctures prepared by macerating aerial parts in alcohol-based solvents for concentrated dosing.
Herbal supplements in tablet or capsule form containing powdered yarrow herb standardized for flavonoid content.
Liquid extracts standardized to consistent polyphenol and essential oil levels for clinical use.
Yarrow-based mouthwash preparations designed to reduce chemotherapy-induced oral mucositis symptoms.
Essential oil blends used as insect repellents in traditional herbal applications.
Hydroalcoholic extracts formulated for research and clinical trial use, with defined phytochemical profiles.